Teosyal® - A New Generation of dermal fillers.
With a high concentration of HA and minimal amounts of Protein and
Bacterial Endotoxins, Teosyal® provides longevity of treatment with minimal
down-time.
Teosyal's purity of ingredients ensures minimal patient
complications
TEOSYAL® is the purest dermal filler available on the market with
less than 0.2 EU/mL of bacterial endotoxins. Each manufacturing stage at
TEOXANE Laboratories is strictly
controlled, from the receipt of raw materials to final packaging, resulting in
a very low presence of bacteria during the manufacturing process. Low levels
of Endotoxins
lead to a limited risk of inflammation, redness and edema.
In a post market survey of over 1000 teosyal® syringes injected:
91% of patients studied showed less immediate post
injection side effects with TEOSYAL® implants.*
100% of practitioners satisfied with
TEOSYAL®.*
76% of practitioners surveyed stated that they are VERY
satisfied with TEOSYAL® implants.*
Low Protein Content- Reduced risk of hypersensitive
reactions
The level of protein in TEOSYAL® is lower than 5
μg/mL which is one of the lowest protein contents on the market. This low
protein content results in a reduced risk of hypersensitive reactions.
Teosyal® offers superior durability and is evident based on high
patient satisfaction
Non-Animal Hyaluronic Acid- Optimal viscoelasticity for a
long lasting durable filling
TEOSYAL® is composed of one of the highest concentrations of hyaluronic
acid on the market. It is a 100% non-animal based ingredient that is
biodegradable and completely biocompatible with human hyaluronic acid. This
high concentration of hyaluronic acid results in a durable, long lasting
effect.
In a post market survey of over 1000 Teosyal® syringes injected:
86% of patients studied showed that TEOSYAL's
filling effect is superior to other hyaluronic acid based products.*
Highly Cross-Linked Monophasic Gel- Less vulnerability to
hydroxyl radicals
TEOSYAL® is a monophasic and homogeneous gel
which results in less vulnerability to hydroxyl radicals for a delayed
degradation. TEOSYAL® gels are cross-linked in
order to lengthen life expectancy in the dermis which in turn strengthens the
macro-molecules of hyaluronic acid.
66% of patients studied showed that TEOSYAL®
outlasted other hyaluronic acid based products.*
Teosyal® offers the latest in technological advancements
 Patented Syringe 360° Rotation- Designed for greater precision
and comfort
This patented syringe offers enhanced injection
capabilities providing optimal dosage control. Designed to facilitate injection
of the product, the wide diameter of the piston and the increased size of the
plunger provides more control and comfort when holding the syringe. Its
360º rotation allows easy manipulation of the needle's angle. For
added convenience this patented syringe has a luer lock built into the body of
the syringe to prevent any risk of product leakage.
TEOXANE Manufacturing Facilities
Teoxane's
state-of-the-art manufacturing facility was created and accomplished in
conformity with FDA standards. This facility is specifically designed for the
manufacturing of TEOSYAL® gels and has a sterile room equipped with the
latest in technological advancements. Each manufacturing stage is strictly
controlled with numerous tests
(sterility test, bacterial endotoxins, pH) carried out on each batch of the
TEOSYAL® product line. All procedures are done in conformity with strict
European manufacturing norms and processes to ensure TEOSYAL's quality
product.
Read Brochure (pdf).
* Results of a Post Market Survey - Realized in October 2005 on 1052
TEOSYAL® syringes (60% TEOSYAL® 27G, 34% TEOSYAL® 30G and 6%
TEOSYAL® Meso) injected for more than 3 months.
Bacterial Endotoxins- A low level of endotoxins means next-to-no down
time
| 